--2024/Q4-- / 0.000--
Coinbase
COIN
Strategy
MSTR
Tesla
TSLA
Salesforce
CRM
Meta Platforms
META
US Stock MarketDetailed Quotes
ACTU Actuate Therapeutics
- 7.015
- -0.265-3.64%
Trading Mar 11 12:34 ET
137.01MMarket Cap-4.81P/E (TTM)
7.250High6.915Low9.86KVolume7.250Open7.280Pre Close69.03KTurnover0.15%Turnover RatioLossP/E (Static)19.53MShares11.73052wk High25.60P/B46.27MFloat Cap5.51052wk Low--Dividend TTM6.60MShs Float11.730Historical High--Div YieldTTM4.60%Amplitude5.510Historical Low6.998Avg Price1Lot Size
Actuate Therapeutics Key Stats
Actuate Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency:
Actual
Estimate
Actuate Therapeutics Earnings Reports
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.